期刊文献+

奥沙利铂联合亚叶酸钙及氟尿嘧啶治疗晚期大肠癌的临床分析 被引量:6

Clinical analysis of treating advanced colorectal cancer by oxaliplatin combined with leucovorin and 5-fluorouraci
下载PDF
导出
摘要 目的观察奥沙利铂联合亚叶酸钙及氟尿嘧啶方案治疗晚期大肠癌的临床疗效及毒副反应。方法 64例晚期大肠癌患者给予化疗方案为:L-OHP 130 mg/m2静脉点滴2 h,d1;CF 200 mg/m2,静脉点滴2 h,d1;5-FU 400 mg/m2静脉推注,后2 400 mg/m2微泵持续静脉滴注48 h。每2周重复,4周为1个周期,完成2个周期后判定疗效,按WHO标准评价客观疗效和毒副反应。结果全组64例均可评价疗效,其中完全缓解8例,部分缓解24例,稳定18例,进展14例,总有效率CR+PR=50.0%。中位肿瘤进展时间为5.6个月,中位生存时间为9.5个月。毒副反应主要是骨髓抑制、胃肠道反应及外周神经毒性。结论奥沙利铂联合亚叶酸钙及氟尿嘧啶方案治疗晚期肠癌患者的近期疗效较好,毒副反应可以耐受,值得进一步研究应用。 Objective To evaluate the efficacy and toxicity of oxaliplatin combined with leucovorin and 5-fluorouracil in treating advanced colorectal cancer. Methods 64 patients with advanced colorectal cancer were treated with chemotherapy of regimen:Oxaliplatin 130 mg/m2,ivgtt,dl;CF 200 mg/m2 ,ivgtt 2 h followed by 5-Fu 400 mg/m2 (bolus) and 5-Fu 2400 mg/m2 (48 h-coutinous infusion)and repeated every 2 weeks,4 Weeks for one cycle.All patients received two cycles of chemotherapy at least.Efficacy was evaluated after 2 cycles. Results 8 patients achieved complete remission CR,24 patients partial remission PR,18 patients stable disease SD,14 patients progression disease PD.Overall response rate was 50.0%.The median time toprogression mTTP was 5.6months.The median survival time MST was 9.5 months.The major toxicity included leucopenia,nausea,vomiting and neurosensory abnormity. Conclusion It was concluded that with the regimen of the regimen of oxaliplatin in combination with CF,5-FU is effective and tolerable in advanced colorectal cancer.
作者 胡达水
出处 《中国医药科学》 2012年第9期78-79,共2页 China Medicine And Pharmacy
关键词 晚期大肠癌 奥沙利铂 亚叶酸钙 氟尿嘧啶 化疗 Advanced gastric cancer Oxaliplatin Leucovorin 5-fluorouraci Ghemotherapy
  • 相关文献

参考文献6

二级参考文献14

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2[1]Raymond E,Buquet-Fagot C,et al.Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon,breast,and ovarian cancers.Anticancer Drugs,1997,8:876
  • 3[2]De Gramont,Figer A,et al.Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.J Clin Oncol,2000,18:2938
  • 4[3]Goldberg RM,Sargent DJ,et al.A randomized controlled trial of fluorouracil plus leucovorin,irinotecan,and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.J Clin Oncol,2004,22:23
  • 5[4]Delaunoit T,Alberts SR,Sargent DJ,et al.Chemotherapy permits resection of metastatic colorectal cancer:Experience from Intergroup N9741.Ann Oncol,2005,16 (3):425
  • 6[5]Alberts SR,Horvath WL,Sternfeld WC,et al.Oxaliplatin,fluorouracil,and leucovorin for patients with unresectable liveronly metastases from colorectal cancer:A North Central Cancer Treatment Group phase Ⅱ study.J Clin Oncol,2005,23:9243-9249.
  • 7孙燕,临床肿瘤内科手术 第3版(第3版),1996年,33-101,214-215页
  • 8de Gramont A, Figer A, Seymour M,et al. Leucovorin and 5-Fluorouracil with or without Oxaliplatin as First-line treatment in Advanced Colorectal Cancer [J]. J Clin Oncol, 2000,18:2938-2947.
  • 9Paul-B, Villejuif. Oxaliplatin in practice[J]. Br J Cancer, 1998, 77(4):4-7(Suppl).
  • 10Lim W, Koo W, AUE, et al. Continuous infusion 5-Fliuorouracil as salvage chemotherapy in patients with advanced colorectal cancer[J]. Ann-Acad-Med-Singapore,1999,28(2):256-259.

共引文献352

同被引文献44

  • 1赵亚恒.用奥沙利铂联合氟尿嘧啶和四氢叶酸钙治疗晚期大肠癌的疗效观察[J].求医问药(下半月刊),2012,10(12):613-614. 被引量:2
  • 2李玉明,詹文华,韩方海,何裕隆,彭俊生,蔡世荣,马晋平,赵刚.胃癌复发的类型、时间和危险因素分析[J].中华外科杂志,2006,44(3):174-176. 被引量:30
  • 3Parkin D M;Bray F;Ferlay J.Global cancer staistics,2005(02).
  • 4Steele G Jr. Adjuvant therapy for patients with colon and rectal cancer:clinical indications for muhimodality therapy in high-risk groups and specific surgical questions for future muhimodality tri- Ms. Surgery, 1992,112 ( 5 ) : 847-849.
  • 5Steele G Jr, Posner MR. Adjuvant treatment of clorectal adenocar-cinoma. Curr Probl Cancer, 1993,17 (4) :223-229.
  • 6Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin ,2005,55 ( 1 ) : 10-30.
  • 7NIH Consensus Conference. Adjuvant therapy for patients with co- lon and rectal cancer. J Am Med Assoc, 1990,64 ( 11 ) : 1444- 1450.
  • 8Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovor- in-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol, 1993,'11 (10) :1879-1887.
  • 9Sato S,Itamochi H,Kigawa J,et al.Combination chemotherapy of oxaliplatin and 5-fluorouracilmay be an effective regimen formucinous adenocarcinoma of the ovary:a potential treatment strategy[J].Cancer Sci,2009,100(3):546-551.
  • 10Hardy D,Cormier JN,Xing Y,et al.Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancee[J].J Thorac Oncol,2010,5(1):90-98.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部